RNAi Drug Delivery: Technologies and Global Markets

1
RNAi Drug Delivery Technologies and Global
Markets
One-Stop Shop for Business Information
2
Summary
The global market for RNAi drug delivery
technologies reached nearly 9.3 billion in 2012
and nearly 11.7 billion in 2013. This market is
expected to grow to 38.8 billion in 2018, with a
compound annual growth rate(CAGR) of 27.2 from
2013 to 2018. This report provides -Analyses
of global market trends, with data from 2012,
estimates for 2013, and projections of compound
annual growth rates (CAGRs) through 2018.
3
-An overview of the global market for RNA
interference (RNAi) in major therapeutic and drug
delivery areas. -Details on application areas
including infectious diseases, cancer,
inflammation/immune dysfunction, central nervous
system (CNS) disorders, and cardiology/metabolism.
-Identification of the driving factors for
demand in the market -Discussion of emerging
technologies. -Comprehensive company profiles of
major players in the industry.
4
Reason for Doing the Study
Since its discovery in 1998 by two scientists,
the naturally occurring RNA interference effect
has been hailed as the hottest technical
breakthrough in biological research. It may even
surpass polymerase chain reaction (PCR) as a top
technology. RNA interference allows scientists to
silence the expression or effect of a gene being
studied. Known simply as RNAi, this field has
rapidly emerged as a fast-growing new market.
This report assesses this emerging commercial
market and maps the key RNAi therapeutic and drug
delivery players on the market landscape. It also
evaluates competitors and collaborators in the
developing RNAi technologies and examines the
latest RNAi-related patenting trends.
5
SCOPE OF REPORT The latest trends in RNAi
therapeutics are examined, focusing on the main
areas of clinical need, general/proprietary
technologies, and company pipelines, and the
activities and strategies of RNAi-based
developers are profiled. This report also
provides forecasts for market growth to 2018
across major RNAi market segments. This report
provides an in-depth assessment of recent
progress and future opportunities for RNAi
players in major therapeutic areas.
6
Methodology
Primary and secondary research methodologies, as
well as interviews with key players in the RNAi
field were used in preparing this report.
Secondary sources include books, newspapers,
trade journals, white papers, industry portals,
government agencies, trade associations,
monitoring industry news and developments, and
through access to paid databases. The base year
of the report is 2013, with forecast data
provided through 2018. Historical, base year and
forecast data are provided for each market
segment of this report. Growth rates are
determined through a compilation of data,
including past trends, future trends,
demographics, incidence, mortality, products in
research and development (RD), and current
product growth, etc. 
7
Table Of Content

1. INTRODUCTION
2. SUMMARY
3. OVERVIEW
4. RNAI DRUG DELIVERY
5. RNAI-BASED THERAPEUTICS
6. RNAI LANDSCAPE
7. RNAI DRUG DELIVERY-MARKET DATA
8. RNAI DRUG DELIVERY STRATEGIES AND CURRENT MARKET
   DYNAMICS
9. COMPANY PROFILES
10. MARKET SHIFTS IN RNAI SPACE

8

• To know more
• RNAi Drug Delivery Technologies and Global
  Markets

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com